Shamburg News · 8-K filed Nov 13, 2026, 4:06 PM EST

OptimizeRx Reports Q3 2026 Results and Updates 2026 Revenue Guidance to $87-$93 Million

OPRX · OptimizeRx Corp

  • Earnings
  • Materiality: high

OptimizeRx Corporation reported third quarter 2026 revenue of $21.6 million, down 17% from $26.1 million a year earlier, and GAAP net income of $1.2 million, or $0.06 per basic and diluted share. Non-GAAP net income was $3.8 million, or $0.20 per diluted share, and adjusted EBITDA was $6.3 million. The company updated its fiscal 2026 revenue guidance to $87 million to $93 million and left adjusted EBITDA guidance unchanged at $21 million to $25 million.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001448431-26-000022.

Written from the filing by Shamburg Markets. Figures are as reported by the company.